Discontinuation report EPIRUBICIN FOR INJECTION
Report ID | 126906 |
Drug Identification Number | 02324091 |
Brand name | EPIRUBICIN FOR INJECTION |
Common or Proper name | EPIRUBICIN FOR INJECTION 2mg/ml |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | EPIRUBICIN HYDROCHLORIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ML |
ATC code | L01DB |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-10-23 |
Actual discontinuation date | 2020-10-23 |
Remaining supply date | 2020-10-23 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued as of Oct 23 2020 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-10-24 | English | Compare |
v2 | 2020-10-22 | French | Compare |
v1 | 2020-10-22 | English | Compare |
Showing 1 to 3 of 3